Onco-innovations Ltd. Stock
€0.97
Your prediction
Financial data and news for Onco-innovations Ltd.
sharewise wants to provide you with the best news and tools for Onco-innovations Ltd., so we directly link to the best financial data sources.
Financials
News
Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
Vancouver, Canada – December 07, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) (“Onco” or the “Company”) is pleased to announce that it has
Onco-Innovations Attends University of Alberta’s 2025 Innovation Awards
Vancouver, Canada – November 25, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (Frankfurt: W1H, WKN: A3EKSZ)(OTCQB: ONNVF) ("Onco" or the "Company") is pleased to announce that it was
Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies
Vancouver, Canada – November 20, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that its
Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development
Vancouver, Canada – November 18, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that it is
Onco-Innovations’ Inka Health Publishes Framework on Transportability of Real-World Evidence and Use in Health Technology Assessment
Vancouver, Canada – November 7, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (Frankfurt: W1H, WKN: A3EKSZ)(OTCQB: ONNVF) ("Onco" or the "Company") is pleased to announce that its
Onco-Innovations Provides Shareholder Update Following Cboe Canada Investor Spotlight
Focus on U.S. Strategy
Vancouver, Canada – October 31, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to
Onco-Innovations Announces Closing of Private Placement
Not for distribution to United States wire services or for dissemination in the United States
Vancouver, Canada – October 27, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (Frankfurt: W1H
Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology
Vancouver, Canada – September 28, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that
Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies
Vancouver, Canada – September 19, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that Dalton
Onco-Innovations to Chair Colorectal Cancer Canada Precision Oncology Forum Driving the Future of Cancer Care
Vancouver, Canada – September 12, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (Frankfurt: W1H, WKN: A3EKSZ)(OTCQB: ONNVF) ("Onco" or the "Company") is pleased to announce that its
Onco-Innovations Appoints Dr. John Mackey to Scientific & Clinical Advisory Board
Vancouver, Canada – September 5, 2025 – Onco-Innovations Limited (CBOE CA:
Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised
Vancouver, Canada – August 15, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (Frankfurt: W1H, WKN: A3EKSZ)(OTCQB: ONNVF) ("Onco" or the "Company") is pleased to announce the successful
Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement
Vancouver, Canada – August 4, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce it has entered
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
Reduce development timelines and costs, while improving access to
Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
Vancouver, Canada – July 20, 2025 – Onco-Innovations Limited (CBOE CA: ONCO
Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology
Vancouver, Canada – July 11, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that it has entered
Onco-Innovations Strengthens Clinical Leadership with Appointment of Dr. Islam Mohamed as Advisory Board Chair
Vancouver, Canada – July 10, 2025 – Onco-Innovations Limited (CBOE CA: ONCO)
Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials
Vancouver, Canada – July 4, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that it has entered
Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors’ Conference Call
Vancouver, Canada – July 2, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that on July 2, 2025,
Onco-Innovations Welcomes AstraZeneca’s Interest in Founding Role in PROmAI - an Inka-led AI-Oncology Consortium
Vancouver, Canada – June 27, 2025 – Onco-Innovations Limited (CBOE CA: ONCO)
Onco-Innovations’ CEO to Host Special Investors’ Conference Call on Wednesday, July 2, 2025
Vancouver, Canada – June 25, 2025 – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce that Mr. Thomas
Inka Health Co-Founders Publish New Study Advancing Real-World Applicability of Lung Cancer Clinical Trial Outcomes
Vancouver, Canada – June 20, 2025 – Onco-Innovations Limited (CBOE CA: ONCO
Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers
Vancouver, Canada - June 13, 2025 - Onco-Innovations Limited (CBOE: ONCO)